ALS Research

As an ALSA Certified Center of Excellence for the treatment of ALS, we are committed to participating in research studies to improve our understanding of the disease and work towards new treatments.  We are currently involved in the following studies:

Amyotrophic Lateral Sclerosis (ALS) ALSA – BIO3: Fluid Biomarkers with Deep Phenotyping in Patients with ALS .
The primary objective of the study is to obtain deep phenotyping information on patients with ALS, studied at regular intervals over 18 months, in conjunction with biofluid collection over that same time period.
Clinical Investigator:  Twydell, Paul

Contact: 
Brandon James
Brandon.James@spectrumhealth.org
616.486.2058